Health Canada drug identification number

DIN 02412292 — GEMCITABINE INJECTION 40 MG

GEMCITABINE INJECTION is a solution of Gemcitabine marketed by SANDOZ CANADA INCORPORATED. The full Gemcitabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02412292
Brand name
GEMCITABINE INJECTION
Active ingredient
Gemcitabine
Strength
40 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Nucleoside analog antimetabolite (antineoplastic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Gemcitabine products

DINBrandStrengthFormManufacturerStatus
02402831 GEMCITABINE INJECTION 38 MG SOLUTION PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.